Jammin’ Java, Corp. (OTCMKTS:JAMN) Moves Up on Bob Marley Branding
Jammin’ Java, Corp. (OTCMKTS:JAMN) cannot compete with the volume and price spikes from its promotional days in 2011, but this year has seen the company trading more robustly, holding up in price and in the past few days charting a rising trend to 45 cents after adding more than 21%. 
The latest climb may be due to news about a possible revival in the company’s coffee business, which has been struggling for long months. JAMN paid well for the right to use Bob Marley’s name in its brand of coffee, Marley Coffee. Now specialists David Roth and Rick Bacher will care for the brand’s publicity. Hopefully, the fair-trade, organic artisan coffee will start to repay soon. 
JAMN for now stays away from outright pumps, after its ticker sank deeply with the 2011 campaign, but the last month has been very active with press releases, especially concerning the company’s securing of extra capital and the building of a US-wide distribution network.
Currently, the artisan coffee company has the following beans in its bag:
- $65,000 cash
- $1.4 million total assets
- $1.34 million total liabilities
- $1.8 million annual revenues, compared to $403,000 for 2011
So far, JAMN somehow manages to justify its debt with significant revenues, although marking an increase in the net loss to $4 million. This may either be a temporary glitch until JAMN reaches enough customers, or the undoing of the company. Still, at 45 cents the coffee maker is still vulnerable to trading purely on sentiment. It is not improbable that a pumper will join if the stock’s moves gather enough attention.
What makes JAMN improbable is that it does not fit in with currently hot industries on the penny stock markets. Most promotions seek the promise of oil and minerals companies, along with medical marijuana and the IT sector. So JAMN is in a category of its own, a relatively independent selection with something of a long-term potential.
Microcap Millionaires, the latest pumper for JAMN, seems to have stalled, with its latest message on April 8th. Then, it briefly mentioned Sinobiomed, Inc. (OTCMKTS:STOA) and caused a visible spike in the double-zero stock, but a long slow slide sees STOA now at half the value.
While JAMN looks conservative in comparison, it is best to take the potential for success with a grain of salt and stay away unless you can afford to lose a large part of your investment.
